Drug Shortage Report for MYLAN-VERAPAMIL SR
Report ID | 120686 |
Drug Identification Number | 02450488 |
Brand name | MYLAN-VERAPAMIL SR |
Common or Proper name | VERAPAMIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 180MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-01-19 |
Actual start date | 2021-01-20 |
Estimated end date | 2021-03-16 |
Actual end date | 2021-03-16 |
Shortage status | Resolved |
Updated date | 2021-03-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-21 | English | Compare |
v2 | 2020-07-21 | French | Compare |
v3 | 2020-07-28 | English | Compare |
v4 | 2020-07-28 | French | Compare |
v5 | 2020-08-04 | English | Compare |
v6 | 2020-08-04 | French | Compare |
v7 | 2020-09-01 | English | Compare |
v8 | 2020-09-01 | French | Compare |
v9 | 2020-09-14 | English | Compare |
v10 | 2020-09-14 | French | Compare |
v11 | 2020-09-22 | English | Compare |
v12 | 2020-09-22 | French | Compare |
v13 | 2020-09-30 | English | Compare |
v14 | 2020-09-30 | French | Compare |
v15 | 2020-10-14 | English | Compare |
v16 | 2020-10-14 | French | Compare |
v17 | 2020-11-10 | English | Compare |
v18 | 2020-11-10 | French | Compare |
v19 | 2020-12-01 | English | Compare |
v20 | 2020-12-01 | French | Compare |